Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome.

Vetro C, Rosso R, Palmucci S, Russello M, Colletta G, Romeo MA, Ximenes B, Romano A, Palumbo GA, Di Raimondo F.

J Clin Apher. 2015 Sep 28. doi: 10.1002/jca.21434. [Epub ahead of print]

PMID:
26411360
2.

Added value of multi-pathogen probe-based real-time PCR SeptiFast in the rapid diagnosis of bloodstream infections in patients with bacteraemia.

Mongelli G, Romeo MA, Denaro C, Gennaro M, Fraggetta F, Stefani S.

J Med Microbiol. 2015 Jul;64(7):670-5. doi: 10.1099/jmm.0.000074. Epub 2015 Apr 29.

PMID:
25926679
3.

Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.

Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Santangelo C, Castiglione G, Giaquinta L, Romeo MA, Vrioni G, Tsakris A.

J Hosp Infect. 2014 Apr;86(4):260-6. doi: 10.1016/j.jhin.2014.02.001. Epub 2014 Feb 20.

PMID:
24680473
4.

Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.

Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M, Cianciulli P, Caruso V, Romeo MA, Filosa A, Pitrolo L, Putti MC, Peluso A, Campisi S, Missere M, Midiri M, Gulino L, Positano V, Lombardi M, Ricchi P.

J Cardiovasc Magn Reson. 2013 Jan 16;15:1. doi: 10.1186/1532-429X-15-1.

5.

Left ventricular rotational dynamics in Beta thalassemia major: a speckle-tracking echocardiographic study.

Monte I, Buccheri S, Bottari V, Blundo A, Licciardi S, Romeo MA.

J Am Soc Echocardiogr. 2012 Oct;25(10):1083-90. doi: 10.1016/j.echo.2012.07.007. Epub 2012 Aug 14.

PMID:
22898242
6.

Feasibility, reproducibility, and reliability for the T*2 iron evaluation at 3 T in comparison with 1.5 T.

Meloni A, Positano V, Keilberg P, De Marchi D, Pepe P, Zuccarelli A, Campisi S, Romeo MA, Casini T, Bitti PP, Gerardi C, Lai ME, Piraino B, Giuffrida G, Secchi G, Midiri M, Lombardi M, Pepe A.

Magn Reson Med. 2012 Aug;68(2):543-51. doi: 10.1002/mrm.23236. Epub 2011 Nov 29.

PMID:
22127999
7.

Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy.

Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, Spanakis N, Giaquinta L, Valenti G, Romeo MA, Tsakris A.

J Clin Microbiol. 2011 Nov;49(11):3986-9. doi: 10.1128/JCM.01242-11. Epub 2011 Sep 7.

8.

Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.

Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Hemoglobin. 2011;35(3):206-16. doi: 10.3109/03630269.2011.570674.

PMID:
21599433
9.

Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation.

Milone G, Poidomani M, Leotta S, Avola G, Camuglia MG, Privitera A, Consoli C, Mercurio S, Romeo MA, Di Marco A, Di Mercurio S, Spadaro A, Palumbo GA, Tedeschi P.

Bone Marrow Transplant. 2012 Jan;47(1):24-32. doi: 10.1038/bmt.2011.33. Epub 2011 Mar 14.

PMID:
21399670
10.

Cross-transmission of Klebsiella pneumoniae in two intensive care units: intra- and inter-hospital spread.

Agodi A, Barchitta M, Valenti G, Romeo MA, Giaquinta L, Santangelo C, Castiglione G, Tsakris A.

J Hosp Infect. 2011 Mar;77(3):279-80. doi: 10.1016/j.jhin.2010.10.007. Epub 2011 Jan 28. No abstract available.

PMID:
21277048
11.

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.

Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, Putti MC, Lippi A, Romeo MA, Bisconte MG, Filosa A, Caruso V, Quarta A, Pitrolo L, Missere M, Midiri M, Rossi G, Positano V, Lombardi M, Maggio A.

Haematologica. 2011 Jan;96(1):41-7. doi: 10.3324/haematol.2009.019042. Epub 2010 Sep 30.

12.

Genotype-phenotype relationship of the δ-thalassemia and Hb A(2) variants: observation of 52 genotypes.

Lacerra G, Scarano C, Lagona LF, Testa R, Caruso DG, Medulla E, Friscia MG, Mastrullo L, Caldora M, Prezioso R, Gaudiano C, Magnano C, Romeo MA, Musollino G, Di Noce F, Carestia C.

Hemoglobin. 2010;34(5):407-23. doi: 10.3109/03630269.2010.511586.

PMID:
20854114
13.

Emotional impact in beta-thalassaemia major children following cognitive-behavioural family therapy and quality of life of caregiving mothers.

Mazzone L, Battaglia L, Andreozzi F, Romeo MA, Mazzone D.

Clin Pract Epidemiol Ment Health. 2009 Feb 23;5:5. doi: 10.1186/1745-0179-5-5.

14.

Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.

Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Br J Haematol. 2009 Apr;145(2):245-54. doi: 10.1111/j.1365-2141.2009.07609.x. Epub 2009 Feb 19.

PMID:
19236376
15.

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.

Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P.

Blood Cells Mol Dis. 2009 May-Jun;42(3):247-51. doi: 10.1016/j.bcmd.2009.01.002. Epub 2009 Feb 23.

PMID:
19233692
16.

Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients.

Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C, Pennisi C, Agodi A.

Int J Hyg Environ Health. 2009 May;212(3):330-7. doi: 10.1016/j.ijheh.2008.07.001. Epub 2008 Sep 3.

PMID:
18771951
17.

Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area.

Lacerra G, Musollino G, Scarano C, Lagona LF, Caruso DG, Testa R, Prezioso R, Di Noce F, Medulla E, Friscia MG, Mastrullo L, Caldora M, Nota L, Gaudiano C, Magnano C, Ciaccio C, Romeo MA, Carestia C.

Gene. 2008 Feb 29;410(1):129-38. doi: 10.1016/j.gene.2007.12.004. Epub 2007 Dec 14.

PMID:
18221842
18.

Interferon-alpha therapy in Sicilian and Sardinian polytransfused thalassaemic patients with chronic hepatitis C.

Pizzarelli G, Di Gregorio F, Romeo MA, Carboni F, Gallisai D, Solinas A, Malaguarnera M, Musumeci S.

BioDrugs. 1999 Jul;12(1):55-63.

PMID:
18031162
19.

Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients.

Agodi A, Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C.

Intensive Care Med. 2007 Jul;33(7):1155-61. Epub 2007 May 15.

PMID:
17503016
20.

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Piga A, Romeo MA, Zhao H, Cnaan A.

Blood. 2006 May 1;107(9):3733-7. Epub 2005 Dec 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk